Search Results - "Majerus, L"

Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy by Sörensen, A., Carles, M., Bunea, H., Majerus, L., Stoykow, C., Nicolay, N. H., Wiedenmann, N. E., Vaupel, P., Meyer, P. T., Grosu, A. L., Mix, M.

“…Purpose The aim of this study was to investigate whether textural features of tumour hypoxia, assessed with serial [ 18 F]fluoromisonidazole (FMISO)-PET, were…”
Get full text

Chemokines CXCL10 and CXCL11 in the cerebrospinal fluid of patients with tick-borne encephalitis by Lepej, S. Ž., Mišić-Majerus, L., Jeren, T., Rode, O. D., Remenar, A., Šporec, V., Vince, A.

“…Objectives –  The aim of our study was to determine whether cerebrospinal fluid (CSF) of patients with tick‐borne encephalitis (TBE) contains CXCL10, CXCL11,…”
Get full text

PO-114: Alterations in tumour hypoxia in serial FMISO/PET-CT during chemoradiation in HNSCC by Bunea, H, Bunea, A, Majerus, L, Stoykow, C, Mix, M, Grosu, A.L

Get full text

PO-113: Dynamics of biological imaging parameters in PW-MRI and FMISO-PET/CT during chemoradiation of SCCHN by Bunea, A, Bunea, H, Stoykow, C, Majerus, L, Wiedenmann, N, Mix, M, Meyer, P, Bock, M, Grosu, A.L

Get full text

EP-1086: Finding the right threshold for determining hypoxic subvolumes in F-MISO-PET/CTs for HNSCC by Kerti, H, Majerus, L, Bunea, A, Wiedenmann, N, Mix, M, Stoykow, C, Meyer, P.T, Grosu, A.L

Get full text

EP-2059: Changes in hypoxia in serial F-MISO/PET-CT during chemoradiation in HNSCC by Kerti, H, Bunea, A, Majerus, L, Mix, M, Stoykow, C, Wiedenmann, N, Meyer, P.T, Grosu, A.L

Get full text

Dynamics in 18-fluoromisonidazole PET/CT and perfusion-weighted 3-Tesla MRI parameters as biomarkers for predicting treatment outcome in HNSCC by Bunea, H, Bunea, A, Wiedenmann, N, Stoykow, C, Mix, M, Majerus, L, Ludwig, U, Rischke, H.C, Langer, M, Meyer, P.T, Bock, M, Grosu, A.L

“…An abstract of the study conducted by Bunea et al detecting the dynamics of hypoxia during chemoradiation (RCTx) is with FMISO PET/CT and correlated to…”
Get full text

Dynamics in 18-Fluoromisonidazole PET/CT and Perfusion-Weighted 3-Tesla Magnetic Resonance Imaging Parameters as Biomarkers for Predicting Treatment Outcome in Head and Neck Squamous Cell Carcinoma by Bunea, H, Bunea, A, Wiedenmann, N, Stoykow, C, Mix, M, Majerus, L, Ludwig, U, Rischke, H.C, Langer, M, Meyer, P.T, Bock, M, Grosu, A

Get full text

Comparison of azithromycin and doxycycline in the treatment of erythema migrans by Barsic, B, Maretic, T, Majerus, L, Strugar, J

“…A randomized, multicenter, open clinical trial was undertaken in order to compare the efficacies of azithromycin and doxycycline in the treatment of patients…”
Get full text

Dillapiol Derivatives as Synergists: Structure–Activity Relationship Analysis by Belzile, Anne-Sophie, Majerus, Sherry L., Podeszfinski, Catherine, Guillet, Gabriel, Durst, Tony, Arnason, J.Thor

“…The synergistic activity of synthetic derivatives of dillapiol, a naturally occurring synergist, was assessed in combination with the phototoxin…”
Get full text

PO-1695: The utility of multiparametric MRI to characterize hypoxic tumor subvolumes compared to FMISO PET/CT by Wiedenmann, N., Nicolay, N.H., Büchert, M., Rischke, H., Ruf, J., Bielak, L., Majerus, L., Mix, M., Baltas, D., Bock, M., Grosu, A.

Get full text

Imaging Biomarkers Multiparametric 3 Tesla MRI and FMISO Hypoxia PET during Chemoradiotherapy in HNSCC and Their Relation to Outcome by Wiedenmann, N., Bunea, H., Rischke, H.C., Nicolay, N.H., Majerus, L., Bielak, L., Protopopov, A., Ludwig, U., Büchert, M., Stoykow, C., Mix, M., Bock, M., Grosu, A.L.

Get full text

EP-2030 Multiparametric MRI and FMISO PET in HNSCC and its relation with outcome by Wiedenmann, N., Bunea, H., Rischke, H., Bunea, A., Nicolay, N.H., Majerus, L., Bielak, L., Protopopov, A., Ludwig, U., Büchert, M., Stoykow, C., Mix, M., Bock, M., Grosu, A.

Get full text

EP-2296: Effect of radiochemotherapy on T2 MRI signal in HNSCC and its relation to FMISO-PET derived hypoxia by Wiedenmann, N., Bunea, H., Rischke, H., Bunea, A., Majerus, L., Bielak, L., Protopopov, A., Ludwig, U., Büchert, M., Stoykow, C., Mix, M., Meyer, P., Bock, M., Grosu, A.

Get full text

Effect of HNSCC Radiochemotherapy on Imaging Biomarker T2 MRI and its Relation to FMISO-PET Derived Hypoxia by Wiedenmann, N., Bunea, H., Rischke, H.C., Bunea, A., Majerus, L., Bielak, L., Protopopov, A., Ludwig, U., Büchert, M., Stoykow, C., Weber, W., Mix, M., Meyer, P.T., Hennig, J., Bock, M., Grosu, A.

Get full text

169 - Dynamics in 18-fluoromisonidazole PET/CT and perfusion-weighted 3-Tesla MRI parameters as biomarkers for predicting treatment outcome in HNSCC by Bunea, H., Bunea, A., Wiedenmann, N., Stoykow, C., Mix, M., Majerus, L., Ludwig, U., Rischke, H.C., Langer, M., Meyer, P.T., Bock, M., Grosu, A.L.

Get full text

Detection and genotyping of Borrelia burgdorferi sensu lato by polymerase chain reaction by Situm, M, Grahovac, B, Marković, S, Lipozencić, J, Poje, G, Dobrić, I, Marinović, B, Bolanca-Bumber, S, Misić-Majerus, L

“…To isolate and genotype Borrelia burgdorferi genospecies in serum samples of Croatian patients with erythema migrans. DNA isolates from sera of patients with…”
Get full text

New syntheses of dillapiol [4,5-dimetho×y-6-(2-propenyl)-1,3-benzodio×ole], its 4-methylthio and other analogs by Majerus, Sherry L., Alibhai, Najma, Tripathy, Sasmita, Durst, Tony

“…Three syntheses of the natural synergist dillapiol from the natural, commercially available sesamol as starting material, are described. A major difference…”
Get full text

New syntheses of dillapiol [4,5-dimethoxy-6-(2-propenyl)-1,3-benzodioxole], its 4-methylthio and other analogs by Majerus, Sherry L, Alibhai, Najma, Tripathy, Sasmita, Durst, Tony

“…Three syntheses of the natural synergist dillapiol from the natural, commercially available sesamol as starting material, are described. A major difference…”
Get full text

Tularemia transmitted by arthropod bites by Misić-Majerus, L, Bujić, N, Madarić, V

“…The authors present four patients affected with tularaemia in Koprivnica-Krizevci region. The disease occurred in the period from April to September 1994, in 3…”
Get more information